News

Dr. Mirjam Groger from the Bernhard Nocht Institute for Tropical Medicine (BNITM) receives the Wolfgang Stille Science Award 2022 for her outstanding work on the therapy of Lassa haemorrhagic fever

Antibiotics are increasingly failing to work. Even new drugs are often ineffective in treating infections caused by gram-negative pathogens such as Pseudomonas aeruginosa, a relevant causative agent

Approximately 300 million people worldwide are chronically infected with the hepatitis B virus (HBV) and at high risk of developing liver cirrhosis or hepatocellular carcinoma. Consequently, there is

More than one billion people worldwide are at risk of illness, disfigurement, disability, and even death from neglected tropical diseases (NTDs). Especially in the poorest regions of the world where

Prof Anna Hirsch from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now succeeded in acquiring a coveted European Research Council (ERC) grant for the second time. Under the

Bacteria of the genus Enterobacter are among the most dangerous bacteria associated with hospital infections worldwide. Some of their representatives are highly resistant to commonly used antibiotics

The hospital germ Pseudomonas aeruginosa forms biofilms, a kind of mucus layer, to protect itself from attack by the immune system or antibiotics. To form this sticky layer, as well as to successfully

With INCATE (INCubator for Antibacterial Therapies in Europe), the German Center for Infection Research (DZIF) has participated in the foundation of a European initiative to take up the fight against

Hepatitis B virus (HBV) infections remain a major global health problem – according to the World Health Organization (WHO) there are around 300 million HBV carriers worldwide. Current treatments

The 2022 Prize for Translational Infection Research of the German Center for Infection Research (DZIF), endowed with 5,000 euros, goes to the DZIF scientist and epidemiologist Gérard Krause. Prof